Company Filing History:
Years Active: 2025
Title: Meggan Czapiga: Innovator in T Cell Receptor Research
Introduction
Meggan Czapiga is a prominent inventor based in London, GB. She has made significant contributions to the field of immunology, particularly in the area of T cell receptor research. Her innovative work has led to the development of a patented method that enhances our understanding of T cell receptor β chain (TRBC) gene types.
Latest Patents
Meggan Czapiga holds a patent for her invention titled "Molecular assessment of TRBC usage." This invention relates to a method of determining the T cell receptor β chain (TRBC) gene type of a cell. The method involves determining the J gene type expressed in the cell and inferring the TRBC gene type from that information. Additionally, her invention includes the use of CAR T cells targeted to specific TRBC types, as well as methods for medical treatment and nucleic acid probes. She has 1 patent to her name.
Career Highlights
Meggan Czapiga is currently associated with Autolus Limited, a company focused on developing innovative T cell therapies. Her work at Autolus has positioned her as a key player in advancing CAR T cell technology.
Collaborations
Throughout her career, Meggan has collaborated with notable colleagues, including Shimobi Onuoha and Biao Ma. These collaborations have further enriched her research and contributed to the success of her projects.
Conclusion
Meggan Czapiga's contributions to T cell receptor research and her innovative patent demonstrate her commitment to advancing medical science. Her work continues to have a significant impact on the field of immunology.